Warning letter
BHP Holdings Inc. dba BioPure Healing Products: warning letter of Jun 17, 2020
FDA warning letter 597687 · Division of Human and Animal Food Operations West VI
Key facts
| Reference number | 597687 |
|---|---|
| Company | BHP Holdings Inc. dba BioPure Healing Products |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Jun 17, 2020 |
| Posted date | Jun 23, 2020 |
| Issuing office | Division of Human and Animal Food Operations West VI |
| Product type | Food/Cosmetics |
| CFR sections cited | 101, 101.4, 101.7, 101.36, 111, 101.4(h)(1), 101.7(b)(1), 101.4(g), 101.36(b)(2), 101.36(b)(2)(i), 111.560(a), 101.36(c)(1) and 1 more |
| Inspection city | Woodinville |
| Inspection ZIP | 98072 |
| Inspection start date | Oct 15, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: